Hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2013-09-20Clinical Trial Update: Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Hodgkin's Lymphoma [Phase 3]
An update on a Phase 3 trial evaluating a combination chemotherapy regimen for previously untreated advanced Hodgkin lymphoma.
-
CLINICAL_TRIALS research · 2013-08-07Clinical Trial Update: Interferon Alfa-2b Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma [Phase 3]
Phase 3 trial evaluating interferon alfa-2b after chemotherapy and peripheral stem cell transplantation in patients with recurrent or refrac…
-
CLINICAL_TRIALS research · 2013-08-07Clinical Trial Update: Combination Chemotherapy With or Without Radiation Therapy and Peripheral Stem Cell Transplant in Treating Children With Hodgkin's Lymphoma [Phase 2]
This is a Phase 2 clinical trial update evaluating combination chemotherapy with or without radiation therapy and peripheral stem cell trans…
-
CLINICAL_TRIALS research · 2013-08-02Clinical Trial Update: Combination Chemotherapy and/or Radiation Therapy in Treating Young Patients With Hodgkin's Lymphoma [NA]
This document updates the status of a clinical trial evaluating combination chemotherapy and/or radiation therapy for Hodgkin lymphoma in yo…
-
CLINICAL_TRIALS research · 2013-08-02Clinical Trial Update: Carmustine, Etoposide, Cytarabine, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma [Phase 2]
Phase 2 clinical trial evaluating a conditioning regimen of carmustine, etoposide, cytarabine, melphalan, and alemtuzumab followed by donor …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2013-08-02Clinical Trial Update: Radiation Therapy or Combination Chemotherapy in Treating Young Patients With Hodgkin's Lymphoma [NA]
This document provides an update on a clinical trial evaluating radiation therapy or combination chemotherapy for treating Hodgkin lymphoma …
-
CLINICAL_TRIALS research · 2013-07-10Clinical Trial Update: Dual Time Point PET in Lymphoma
This entry reports an ongoing clinical trial evaluating dual time point PET imaging in patients with Hodgkin lymphoma and Non-Hodgkin lympho…
-
CLINICAL_TRIALS research · 2013-01-17Clinical Trial Update: Radiolabeled Monoclonal Antibody With or Without Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Lymphoma [Phase 1]
Phase 1 trial evaluating a radiolabeled monoclonal antibody with or without peripheral stem cell transplantation in children with recurrent …
-
CLINICAL_TRIALS research · 2011-12-13Clinical Trial Update: Functional Assessment of Cancer Therapy - Bone Marrow Transplant
Clinical trial update on Functional Assessment of Cancer Therapy in the bone marrow transplant setting, involving Hodgkin lymphoma and Non-H…
-
CLINICAL_TRIALS research · 2011-12-13Clinical Trial Update: Prospective Data Collection of Newly Diagnosed Hodgkin's Disease and Non-Hodgkin's Lymphoma Cases
This clinical trial update notes prospective data collection of newly diagnosed Hodgkin lymphoma and Non-Hodgkin lymphoma cases at King Fais…
-
CLINICAL_TRIALS research · 2011-07-20Clinical Trial Update: Study Comparing R-mabHD and a Combination of ABVD in Hodgkin's Disease [Phase 2]
Phase 2 clinical trial comparing R-mabHD to ABVD in Hodgkin lymphoma is currently ongoing with the study status listed as UNKNOWN. No result…
-
CLINICAL_TRIALS research · 2011-02-21Clinical Trial Update: Etoposide, Methylprednisolone, High-dose Cytarabine and Oxaliplatin (ESHAOx) for Refractory or Relapsed Hodgkin's Lymphoma (HL) [Phase 2]
A Phase 2 clinical trial is testing ESHAOx (etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin) for refractory or relapsed…
-
CLINICAL_TRIALS research · 2010-11-11Clinical Trial Update: Hybrid SPECT/CTCA for the Assessment of the Presence and Hemodynamic Significance of CAD in Asymptomatic Patients. [NA]
This clinical trial update assesses the use of Hybrid SPECT/CTCA imaging to determine the presence and hemodynamic significance of coronary …
-
CLINICAL_TRIALS research · 2010-10-29Clinical Trial Update: Host Dendritic Cells in Allograft Patients [Phase 1]
Phase 1 clinical trial update from Icahn School of Medicine at Mount Sinai evaluating host dendritic cells in allograft patients for relapse…
-
CLINICAL_TRIALS research · 2009-11-13Clinical Trial Update: Prevalence+Significance of Paraneoplastic Autoantibodies in Many Cancers
A completed clinical trial from Memorial Sloan Kettering studied how common paraneoplastic autoantibodies are across several cancers and whe…
-
CLINICAL_TRIALS research · 2009-11-13Clinical Trial Update: Gonadal Toxicity in Women With Hodgkin Lymphoma
This clinical trial update examines gonadal toxicity in women with Hodgkin lymphoma and discusses the study status and potential reproductiv…
-
CLINICAL_TRIALS research · 2009-03-12Clinical Trial Update: Health and Psychosocial Outcomes in Long-Term Lymphoma Survivors
This clinical trial update reports on health and psychosocial outcomes in people who have survived lymphoma over the long term.
-
CLINICAL_TRIALS research · 2006-10-11Clinical Trial Update: Dual Time Point PET Imaging in Lymphoma
This is a clinical trial update evaluating dual time point PET imaging in Hodgkin lymphoma and non-Hodgkin lymphoma. The current trial statu…